Moderna's Mr. Bancel Was Not Kidding -- When He Said Trump Has Made It "Impossible To Make a Return" -- On New mRNA Vaccine / R&D Candidates...

And as Exhibit A, the chief bio-science architect (and an MD, to boot) of the wildly successful 2021-23 Covid vaccines. . . is departing, in favor of an. . . oncology veteran, with prior experience at Astra-Zeneca -- and Bristol Myers Squibb. Damn.

Here is all of that -- and a bit:

. . .Moderna. . . [announced that] Chief Medical Officer Jacqueline Miller, MD, who led the development of the company's mRNA-based COVID-19 vaccine Spikevax, will step down effective March 2, 2026. . . .

Miller joined Moderna in 2020 as the therapeutic area head for infectious diseases. Her departure comes at a pivotal moment for the company, which is seeking to plug the revenue gap left by waning demand for COVID products and turn its mRNA platform into a broader, durable franchise. . . .

David ⁠Berman will fill the role, as Chief Development Officer, starting March 2, 2026. . . . Before joining Moderna, Berman served as head of research and development at Immunocore and ⁠has previously held senior roles at AstraZeneca and Bristol-Myers ‌Squibb. . . .

Now you know. But Trump and Kennedy Jr. are killing our leadership -- in next gen vaccines, ones that rely on mRNA as the tech. Damn.

नमस्ते